• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体药代动力学建模的统计方法。

Statistical methods for population pharmacokinetic modelling.

作者信息

Racine-Poon A, Wakefield J

机构信息

Pharma Division, Novartis, Basel, Switzerland.

出版信息

Stat Methods Med Res. 1998 Mar;7(1):63-84. doi: 10.1177/096228029800700106.

DOI:10.1177/096228029800700106
PMID:9533262
Abstract

A principal aim of population pharmacokinetic studies is to estimate the variance components associated with intra- and inter-individual variability in observed drug concentrations. The explanation of the inter-individual variability in terms of subject-specific covariates is also of great importance. Pharmacokinetic models are nonlinear in the parameters and estimation is not straightforward. Within this paper we review a number of estimation approaches which have been suggested for population pharmacokinetic analyses. We distinguish between Bayesian and non-Bayesian and fully-parametric, semi-parametric and nonparametric methods.

摘要

群体药代动力学研究的一个主要目标是估计与观察到的药物浓度的个体内和个体间变异性相关的方差分量。根据个体特异性协变量解释个体间变异性也非常重要。药代动力学模型在参数方面是非线性的,估计并不直接。在本文中,我们回顾了一些为群体药代动力学分析建议的估计方法。我们区分了贝叶斯和非贝叶斯方法以及完全参数化、半参数化和非参数化方法。

相似文献

1
Statistical methods for population pharmacokinetic modelling.群体药代动力学建模的统计方法。
Stat Methods Med Res. 1998 Mar;7(1):63-84. doi: 10.1177/096228029800700106.
2
The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.群体药代动力学非线性混合效应模型一阶近似的贝叶斯偏差校正方法
J Biopharm Stat. 2007;17(3):381-92. doi: 10.1080/10543400701199510.
3
Errors-in-variables in joint population pharmacokinetic/pharmacodynamic modeling.联合群体药代动力学/药效学建模中的变量误差
Biometrics. 2001 Sep;57(3):803-12. doi: 10.1111/j.0006-341x.2001.00803.x.
4
An application of Bayesian population pharmacokinetic/pharmacodynamic models to dose recommendation.贝叶斯群体药代动力学/药效学模型在剂量推荐中的应用。
Stat Med. 1995;14(9-10):971-86. doi: 10.1002/sim.4780140917.
5
Bayesian nonparametric population models: formulation and comparison with likelihood approaches.贝叶斯非参数总体模型:公式化及与似然方法的比较
J Pharmacokinet Biopharm. 1997 Apr;25(2):235-53. doi: 10.1023/a:1025736230707.
6
Functional uniform priors for nonlinear modeling.用于非线性建模的功能均匀先验
Biometrics. 2012 Sep;68(3):893-901. doi: 10.1111/j.1541-0420.2012.01747.x. Epub 2012 Jul 27.
7
Effect of a 15-minute infusion of DDAVP on the pharmacokinetics and pharmacodynamics of REVASC during a four-hour intravenous infusion in healthy male volunteers.
Thromb Haemost. 1997 Jan;77(1):127-32.
8
Semiparametric regression in capture-recapture modeling.捕获-再捕获建模中的半参数回归
Biometrics. 2006 Sep;62(3):691-8. doi: 10.1111/j.1541-0420.2005.00514.x.
9
Nonparametric density estimation applied to population pharmacokinetics.
Math Biosci. 1996 Apr 1;133(1):51-68. doi: 10.1016/0025-5564(95)00079-8.
10
Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.采用马尔可夫链蒙特卡罗(MCMC)方法,通过贝叶斯方法对血浆中药物浓度的稳态达到情况进行建模。
Pharm Stat. 2008 Jan-Mar;7(1):36-41. doi: 10.1002/pst.263.

引用本文的文献

1
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients.用于评估重症患者亚胺培南浓度达到目标概率的参数和非参数群体药代动力学模型
Pharmaceutics. 2021 Dec 16;13(12):2170. doi: 10.3390/pharmaceutics13122170.
2
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate.群体药代动力学研究:重症患者中亚胺培南的药代动力学特征——参数法和非参数法均表明慢性肾脏病流行病学合作方程估算肾小球滤过率是一个重要的混杂因素。
Clin Pharmacokinet. 2020 Jul;59(7):885-898. doi: 10.1007/s40262-020-00859-1.
3
Stochastic nonlinear mixed effects: a metformin case study.
随机非线性混合效应:二甲双胍案例研究
J Pharmacokinet Pharmacodyn. 2016 Feb;43(1):85-98. doi: 10.1007/s10928-015-9456-7. Epub 2015 Nov 19.
4
Bayesian immunological model development from the literature: example investigation of recent thymic emigrants.基于文献的贝叶斯免疫学模型构建:近期胸腺迁出者的实例研究
J Immunol Methods. 2014 Dec 1;414:32-50. doi: 10.1016/j.jim.2014.08.001. Epub 2014 Aug 29.
5
Model identification using stochastic differential equation grey-box models in diabetes.使用随机微分方程灰箱模型进行糖尿病中的模型识别
J Diabetes Sci Technol. 2013 Mar 1;7(2):431-40. doi: 10.1177/193229681300700220.
6
A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model.一种用于在测量时间不确定情况下进行估计的连续时间自适应粒子滤波器及其在血浆亮氨酸混合效应模型中的应用。
BMC Syst Biol. 2013 Jan 19;7:8. doi: 10.1186/1752-0509-7-8.
7
Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.关于评估基因和环境对人类癌症发生的联合效应的累积证据的建议和拟议准则。
Int J Epidemiol. 2012 Jun;41(3):686-704. doi: 10.1093/ije/dys010. Epub 2012 May 16.
8
A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study.在群体药代动力学研究中存在人为异常值时的贝叶斯分层非线性混合模型。
J Pharmacokinet Pharmacodyn. 2011 Oct;38(5):613-36. doi: 10.1007/s10928-011-9211-7. Epub 2011 Aug 17.
9
A novel global search algorithm for nonlinear mixed-effects models using particle swarm optimization.一种基于粒子群优化的非线性混合效应模型全局搜索新算法。
J Pharmacokinet Pharmacodyn. 2011 Aug;38(4):471-95. doi: 10.1007/s10928-011-9204-6. Epub 2011 Jun 30.
10
Use of pathway information in molecular epidemiology.在分子流行病学中使用途径信息。
Hum Genomics. 2009 Oct;4(1):21-42. doi: 10.1186/1479-7364-4-1-21.